Henderson Molly
SEC insider (Form 3/4/5 filer). CIK 0001363812. CFO and CBO at Phathom Pharmaceuticals, Inc. (PHAT). 4 reported Form 4/5 transactions since Sep 2024; latest on Apr 7, 2025. Located in FLORHAM, NJ.
Companies Henderson Molly has filed insider reports for
- Phathom Pharmaceuticals, Inc. (PHAT): Officer, CFO and CBO
Henderson Molly
CIK: 0001363812
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (75.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PHAT
Phathom Pharmaceuticals, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Apr 7, 2025PHAT
Phathom Pharmaceuticals, Inc.
SaleDirect3.7K shares at avg. $4.55$17K - Feb 27, 2025PHAT
Phathom Pharmaceuticals, Inc.
AwardDirect72K shares- - Jan 21, 2025PHAT
Phathom Pharmaceuticals, Inc.
SaleDirect6.6K shares at avg. $6.59$43K - Dec 19, 2024PHAT
Phathom Pharmaceuticals, Inc.
SaleDirect1.3K shares at avg. $8.00$10K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 7, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Sale | 3,678 | $4.55 | $16,740 | Direct |
| Feb 27, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Award | 72,000 | - | - | Direct |
| Jan 21, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Sale | 6,583 | $6.59 | $43,371 | Direct |
| Dec 19, 2024 | PHAT Phathom Pharmaceuticals, Inc. | Sale | 1,291 | $8.00 | $10,328 | Direct |
1-4 of 4 transactions